Joyce Shirinde1, Janine Wichmann2, Kuku Voyi2. 1. Department of Environmental Health, Tshwane University of Technology, Pretoria, South Africa. 2. Health Sciences Faculty, School of Health Systems and Public Health, University of Pretoria, Pretoria, South Africa.
Abstract
OBJECTIVE: The aim of this study was to investigate the association between eczema ever (EE) and current eczema symptoms (ES) in relation to exposure to environmental tobacco smoke (ETS). DESIGN: A cross-sectional study using the International Study of Asthma and Allergies in Childhood questionnaire. SETTING: 16 schools were randomly selected from two neighbourhoods situated in Ekurhuleni Metropolitan Municipality, Gauteng Province, South Africa. PARTICIPANTS: From a total population of 3764 school children aged 12-14 years, 3468 completed the questionnaire (92% response rate). A total of 3424 questionnaires were included in the final data analysis. PRIMARY OUTCOME: The prevalence of EE and current ES was the primary outcome in this study. RESULTS: Data were analysed using Multilevel Logistic Regression Analysis (MLRA). The likelihood of EE was increased by exposure to ETS at home (OR 1.30 95% CI 1.01 to 1.67) and at school (OR 1.26 95% CI 1.00 to 1.60). The likelihood of EE was lower for males (OR 0.66 95% CI 0.51 to 0.84). The likelihood of ES was increased by ETS at home (OR 1.93 95% CI 1.43 to 2.59) and school (1.44 95% CI 1.09 to 1.90). The likelihood of ES was again lower for males (OR 0.56 95% CI 0.42 to 0.76). Smoking by mother/female guardian increased the likelihood of EE and ES, however, this was not significant in the multivariate analysis. CONCLUSIONS: Symptoms of eczema were positively associated with exposure to ETS at home and school. The results support the hypothesis that ETS is an important factor in understanding the occurrence of eczema. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
OBJECTIVE: The aim of this study was to investigate the association between eczema ever (EE) and current eczema symptoms (ES) in relation to exposure to environmental tobacco smoke (ETS). DESIGN: A cross-sectional study using the International Study of Asthma and Allergies in Childhood questionnaire. SETTING: 16 schools were randomly selected from two neighbourhoods situated in Ekurhuleni Metropolitan Municipality, Gauteng Province, South Africa. PARTICIPANTS: From a total population of 3764 school children aged 12-14 years, 3468 completed the questionnaire (92% response rate). A total of 3424 questionnaires were included in the final data analysis. PRIMARY OUTCOME: The prevalence of EE and current ES was the primary outcome in this study. RESULTS: Data were analysed using Multilevel Logistic Regression Analysis (MLRA). The likelihood of EE was increased by exposure to ETS at home (OR 1.30 95% CI 1.01 to 1.67) and at school (OR 1.26 95% CI 1.00 to 1.60). The likelihood of EE was lower for males (OR 0.66 95% CI 0.51 to 0.84). The likelihood of ES was increased by ETS at home (OR 1.93 95% CI 1.43 to 2.59) and school (1.44 95% CI 1.09 to 1.90). The likelihood of ES was again lower for males (OR 0.56 95% CI 0.42 to 0.76). Smoking by mother/female guardian increased the likelihood of EE and ES, however, this was not significant in the multivariate analysis. CONCLUSIONS: Symptoms of eczema were positively associated with exposure to ETS at home and school. The results support the hypothesis that ETS is an important factor in understanding the occurrence of eczema. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: H Williams; C Robertson; A Stewart; N Aït-Khaled; G Anabwani; R Anderson; I Asher; R Beasley; B Björkstén; M Burr; T Clayton; J Crane; P Ellwood; U Keil; C Lai; J Mallol; F Martinez; E Mitchell; S Montefort; N Pearce; J Shah; B Sibbald; D Strachan; E von Mutius; S K Weiland Journal: J Allergy Clin Immunol Date: 1999-01 Impact factor: 10.793
Authors: C W Warren; L Riley; S Asma; M P Eriksen; L Green; C Blanton; C Loo; S Batchelor; D Yach Journal: Bull World Health Organ Date: 2000 Impact factor: 9.408
Authors: Christina E Ciaccio; Anita C DiDonna; Kevin Kennedy; Charles S Barnes; Jay M Portnoy; Lanny J Rosenwasser Journal: Ann Allergy Asthma Immunol Date: 2013-08-20 Impact factor: 6.347
Authors: Arnaldo C Porto Neto; Rafael D'Agostini Annes; Nathalia Mm Wolff; Andréia P Klein; Francisco C Dos Santos; Juliana L Dullius; Marina Gressler; Letícia S Muller; Cristine F Angonese; Sérgio Menna-Barreto Journal: Allergy Asthma Clin Immunol Date: 2006-03-15 Impact factor: 3.406
Authors: M Innes Asher; Alistair W Stewart; Javier Mallol; Stephen Montefort; Christopher K W Lai; Nadia Aït-Khaled; Joseph Odhiambo Journal: Respir Res Date: 2010-01-21